In tumor lesions, CXCR3 expression might be sustained by the presence of pro-inflammatory molecules such as IFNγ that has been shown to sustain Tbx21 expression and subsequently TBET to positively regulate CXCR3 expression at the surface of T cells (125, 126). This evidence concerns the gene IFNG and neoplasm.